Inventiva【6IV】銘柄情報

Inventiva (6IV) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

3.225

( 1.42% )

買値

3.20

売値

3.245

出来高

5,110

3.08 日の範囲 3.26

0.00 52 週間の範囲 0.00

時価総額

711.144M

前日終値

3.18

始値

3.195

時刻

3.2

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

365,716 €

発行済株式数

220,509,705

配当利回り

PER

-1.62

1 株当たり利益 (EPS)

-1.9

歳入

6.76M

純利益

-354.14M

Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. It develops Lanifibranor, a novel peroxisome prolifer... Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. It develops Lanifibranor, a novel peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat adult patients with MASH; and Odiparcil for the treatment of patients with mucopolysaccharidoses. The company also develops TGF-ß, a pre-clinical program for the treatment of idiopathic pulmonary fibrosis. Inventiva S.A. was incorporated in 2011 and is headquartered in Daix, France. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

inventivapharma.com

本社

Daix, France

設立

2026

Inventiva is listed in the Healthcare sector of the Tradegate (DE) with ticker 6IV. The last closing price for Inventiva was 3.18 €. Over the last year, Inventiva shares have traded in a share price range of 0.00 € to 0.00 €.

Inventiva currently has 220,509,705 shares in issue. The market capitalisation of Inventiva is 711.14 € million. Inventiva has a price to earnings ratio (PE ratio) of -1.62.

Inventiva announces Repayment of EIB Loans, Repurchase of a portion of EIB Warrants and the Issuance of the first two tranches under New Debt Financing

Inventiva announces Repayment of EIB Loans, Repurchase of a portion of EIB Warrants and the Issuance of the first two tranches under New Debt...

Inventiva annonce le Remboursement des Prêts BEI, le Rachat d'une partie des BSA BEI et l'émission des deux premières tranches dans le cadre du Nouveau Financement

Inventiva annonce le Remboursement des Prêts BEI, le Rachat d'une partie des BSA BEI et l'émission des deux premières tranches dans le...

Statement of Total Voting Rights and Shares Forming The Company’s Share Capital as of May 22, 2026

Statement of Total Voting Rights and Shares Forming The Company’s Share Capital as of May 22, 2026 Article R. 22-10-23 of the French Commercial...

Combined General Meeting of June 30, 2026 - Availability of the Preparatory Documents

Combined General Meeting of June 30, 2026 - Availability of the Preparatory Documents Daix (France), New York City (New York, United States), June...

Information relative au nombre total de droits de vote et d’actions composant le capital social au 22 mai 2026

Information relative au nombre total de droits de vote et d’actions composant le capital social au 22 mai 2026 Article R. 22-10-23 du Code de...

Assemblée Générale Mixte du 30 juin 2026 - Modalités de mise à disposition des documents préparatoires

Assemblée Générale Mixte du 30 juin 2026 - Modalités de mise à disposition des documents préparatoires Daix (France), New York City (New York...

Inventiva annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris

Inventiva annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris Daix (France), New York City (New York, United...

Inventiva Announces Trading Resumption of its Ordinary Shares on Euronext Paris

Inventiva Announces Trading Resumption of its Ordinary Shares on Euronext Paris Daix (France), New York City (New York, United States), June 2...

Inventiva Announces a Comprehensive Capital Structure Optimization including Debt and Equity Financing in Advance of the Anticipated Phase 3 Readout

Inventiva Announces a Comprehensive Capital Structure Optimization including Debt and Equity Financing in Advance of the Anticipated Phase 3...

Inventiva annonce une optimisation globale de sa structure financière, comprenant un financement obligataire et une offre d'American Depositary Shares, en prévision de la publication attendue des résultats de l'essai de phase 3

Inventiva annonce une optimisation globale de sa structure financière, comprenant un financement obligataire et une offre d'American...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

6IV - Frequently Asked Questions (FAQ)

What is the current Inventiva share price?

The current share price of Inventiva is 3.225 €

How many Inventiva shares are in issue?

Inventiva has 220,509,705 shares in issue

What is the market cap of Inventiva?

The market capitalisation of Inventiva is EUR 711.14M

What is the 1 year trading range for Inventiva share price?

Inventiva has traded in the range of 0.00 € to 0.00 € during the past year

What is the PE ratio of Inventiva?

The price to earnings ratio of Inventiva is -1.62

What is the cash to sales ratio of Inventiva?

The cash to sales ratio of Inventiva is 100.13

What is the registered address of Inventiva?

The registered address for Inventiva is 50 rue de Dijon, Daix, Burgundy, 21121

What is the Inventiva website address?

The website address for Inventiva is inventivapharma.com

Which industry sector does Inventiva operate in?

Inventiva operates in the Biotechnology & Life Sciences sector

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Inventiva (6IV)